Clinical Trial Update: Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

View source ↗

Summary

This clinical trial update reports the efficacy of pantoprazole 20/40 mg once daily in patients aged 12 years and older with gastroesophageal reflux disease sym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Nycomed | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED | Results posted: 2010-09-24